Cannabis is a multifaceted plant with numerous therapeutic properties on one hand, and controversial psychotropic activities on the other hand, which are modulated by CB1 endocannabinoid receptors. Δ9-Tetrahydrocannabinol (Δ9-THC) has been identified as the main component responsible for the psychotropic effects, while its constitutional isomer cannabidiol (CBD) has shown completely different pharmacological properties. Due to its reported beneficial effects, Cannabis has gained global popularity and is openly sold in shops and online. To circumvent legal restrictions, semisynthetic derivatives of CBD are now frequently added to cannabis products, producing "high" effects similar to those induced by Δ9-THC. The first semi-synthetic cannabinoid to appear in the EU was obtained through cyclization and hydrogenation of CBD, and is known as hexahydrocannabinol (HHC). Currently, there is limited knowledge regarding HHC, its pharmacological properties, and its prevalence, as it is not commonly investigated in routine toxicological assays. In this study, synthetic strategies were explored to obtain an excess of the active epimer of HHC. Furthermore, the two epimers were purified and individually tested for their cannabinomimetic activity. Lastly, a simple and rapid chromatographic method employing a UV detector and a high-resolution mass spectrometer was applied to identify and quantify up to ten major phytocannabinoids, as well as the HHC epimers, in commercial cannabis samples.

Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC) / Russo, Fabiana; Vandelli, Maria Angela; Biagini, Giuseppe; Schmid, Martin; Luongo, Livio; Perrone, Michela; Ricciardi, Federica; Maione, Sabatino; Laganà, Aldo; Capriotti, Anna Laura; Gallo, Alfonso; Carbone, Luigi; Perrone, Elisabetta; Gigli, Giuseppe; Cannazza, Giuseppe; Citti, Cinzia. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 13:1(2023), pp. 11061-N/A. [10.1038/s41598-023-38188-5]

Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC)

Russo, Fabiana;Vandelli, Maria Angela;Biagini, Giuseppe;Cannazza, Giuseppe
;
Citti, Cinzia
2023

Abstract

Cannabis is a multifaceted plant with numerous therapeutic properties on one hand, and controversial psychotropic activities on the other hand, which are modulated by CB1 endocannabinoid receptors. Δ9-Tetrahydrocannabinol (Δ9-THC) has been identified as the main component responsible for the psychotropic effects, while its constitutional isomer cannabidiol (CBD) has shown completely different pharmacological properties. Due to its reported beneficial effects, Cannabis has gained global popularity and is openly sold in shops and online. To circumvent legal restrictions, semisynthetic derivatives of CBD are now frequently added to cannabis products, producing "high" effects similar to those induced by Δ9-THC. The first semi-synthetic cannabinoid to appear in the EU was obtained through cyclization and hydrogenation of CBD, and is known as hexahydrocannabinol (HHC). Currently, there is limited knowledge regarding HHC, its pharmacological properties, and its prevalence, as it is not commonly investigated in routine toxicological assays. In this study, synthetic strategies were explored to obtain an excess of the active epimer of HHC. Furthermore, the two epimers were purified and individually tested for their cannabinomimetic activity. Lastly, a simple and rapid chromatographic method employing a UV detector and a high-resolution mass spectrometer was applied to identify and quantify up to ten major phytocannabinoids, as well as the HHC epimers, in commercial cannabis samples.
2023
8-lug-2023
13
1
11061
N/A
Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC) / Russo, Fabiana; Vandelli, Maria Angela; Biagini, Giuseppe; Schmid, Martin; Luongo, Livio; Perrone, Michela; Ricciardi, Federica; Maione, Sabatino; Laganà, Aldo; Capriotti, Anna Laura; Gallo, Alfonso; Carbone, Luigi; Perrone, Elisabetta; Gigli, Giuseppe; Cannazza, Giuseppe; Citti, Cinzia. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 13:1(2023), pp. 11061-N/A. [10.1038/s41598-023-38188-5]
Russo, Fabiana; Vandelli, Maria Angela; Biagini, Giuseppe; Schmid, Martin; Luongo, Livio; Perrone, Michela; Ricciardi, Federica; Maione, Sabatino; Laganà, Aldo; Capriotti, Anna Laura; Gallo, Alfonso; Carbone, Luigi; Perrone, Elisabetta; Gigli, Giuseppe; Cannazza, Giuseppe; Citti, Cinzia
File in questo prodotto:
File Dimensione Formato  
s41598-023-38188-5.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 2.22 MB
Formato Adobe PDF
2.22 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1310086
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 10
social impact